바로가기 및 건너띄기 링크: 본문 바로가기; 주메뉴 바로가기

글로벌제약산업정보

임상정보

국내 바이오의약품 임상 현황 (2022/2/21 ~ 2022/2/25)

국내 바이오의약품 임상 현황 (2022/2/21 ~ 2022/2/25) : 작성자, 작성일, 조회수, 출처,원문, 정보 제공
작성자	관리자
작성일	2022-03-03	조회수	534
국가정보	아시아>대한민국
출처	식품의약품안전처
원문	https://nedrug.mfds.go.kr/searchClinic

국내 바이오의약품 임상시험 현황입니다.

○기간: 2022.2.21. ~ 2022.2.25.

○출처: 의약품안전나라(의약품통합정보시스템) > 의약품등 정보 > 임상시험정보 > 임상시험정보공개 (링크 바로가기)

의뢰자	제품명	임상시험제목	임상시험 단계	개발지역	승인일
한국아이큐비아(주)	CAEL-101	Mayo stage IIIb AL 아밀로이드증이 있으며 형질 세포 질환 치료 경험이 없는 시험대상자에서 CAEL-101 과 형질 세포 질환 치료 병용요법 대 위약과 형질 세포 질환 치료 병용요법의 유효성 및 안전성을 평가하는 제3상, 이중 눈가림, 다기관 시험	3상	국외개발	2022-02-25
한국파렉셀주식회사	MEDI4736, MEDI9447, IPH2201	절제 가능한 조기 병기 (II ~ IIIA) 비소세포 폐암 환자에 대한 수술 전 보조 및 수술 후 보조 치료의 제2상 라벨 공개, 다기관, 무작위 배정 임상시험 (NeoCOAST-2)	2상	국외개발	2022-02-24
코반스코리아서비스유한회사	STRO-001	진행성 B세포 악성종양 환자를 대상으로 한 항-CD74 항체 약물 접합체인 STRO-001의 제1상 공개, 안전성, 약동학 및 예비 유효성 시험	1상	국외개발	2022-02-23
피피디디벨럽먼트피티이엘티디	NGM707	진행성 또는 전이성 고형암에서 단독요법 및 펨브롤리주맙과 병용요법으로의 NGM707에 대한 제1/2상 용량 증가/확장 임상시험	1/2상	국외개발	2022-02-21

이전글 해외 바이오의약품 임상 현황 (2022/2/14 ~ 2022/2/20)
다음글 해외 바이오의약품 임상 현황 (2022/2/7 ~ 2022/2/13)

<p align="left" style="margin: 0px; padding: 0px; color: rgb(125, 125, 125); text-transform: none; text-indent: 0px; letter-spacing: normal; font-family: 'Nanum Gothic'; font-size: 13px; font-style: normal; font-weight: 400; word-spacing: 0px; white-space: normal; box-sizing: inherit; orphans: 2; widows: 2; background-color: rgb(255, 255, 255); text-decoration-color: initial; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-thickness: initial; text-decoration-style: initial; text-size-adjust: none;" 255,="" rgb(255,="" 13px;="" nanum="">국내 바이오의약품 임상시험 현황입니다.<span style="color: rgb(125, 125, 125); text-transform: none; text-indent: 0px; letter-spacing: normal; font-family: 나눔고딕, NanumGothic, sans-serif; font-size: 10pt; font-style: normal; font-weight: 400; word-spacing: 0px; white-space: normal; box-sizing: inherit; orphans: 2; widows: 2; background-color: rgb(255, 255, 255); text-decoration-color: initial; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-thickness: initial; text-decoration-style: initial; text-size-adjust: none;">
 
 
<p style="margin: 0px; padding: 0px; color: rgb(125, 125, 125); text-transform: none; text-indent: 0px; letter-spacing: normal; font-family: 'Nanum Gothic'; font-size: 13px; font-style: normal; font-weight: 400; word-spacing: 0px; white-space: normal; box-sizing: inherit; orphans: 2; widows: 2; background-color: rgb(255, 255, 255); text-decoration-color: initial; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-thickness: initial; text-decoration-style: initial; text-size-adjust: none;" 255,="" rgb(255,="" 13px;="" nanum="">○기간: 2022.2.21. ~ 2022.2.25.
<p style="margin: 0px; padding: 0px; color: rgb(125, 125, 125); text-transform: none; text-indent: 0px; letter-spacing: normal; font-family: 'Nanum Gothic'; font-size: 13px; font-style: normal; font-weight: 400; word-spacing: 0px; white-space: normal; box-sizing: inherit; orphans: 2; widows: 2; background-color: rgb(255, 255, 255); text-decoration-color: initial; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-thickness: initial; text-decoration-style: initial; text-size-adjust: none;" 255,="" rgb(255,="" 13px;="" nanum="">○출처: 의약품안전나라(의약품통합정보시스템) > 의약품등 정보 > 임상시험정보 > 임상시험정보공개 (<a style="border: 0px currentColor; border-image: none; color: rgb(125, 125, 125); text-decoration: none; box-sizing: inherit; text-size-adjust: none;" href="https://nedrug.mfds.go.kr/searchClinic" target="_self">링크 바로가기</a>)
<p style="margin: 0px; padding: 0px; color: rgb(125, 125, 125); text-transform: none; text-indent: 0px; letter-spacing: normal; font-family: 'Nanum Gothic'; font-size: 13px; font-style: normal; font-weight: 400; word-spacing: 0px; white-space: normal; box-sizing: inherit; orphans: 2; widows: 2; background-color: rgb(255, 255, 255); text-decoration-color: initial; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-thickness: initial; text-decoration-style: initial; text-size-adjust: none;" 255,="" rgb(255,="" 13px;="" nanum=""> 
<table style="border: currentColor; border-image: none; color: rgb(125, 125, 125); text-transform: none; letter-spacing: normal; font-family: 'Nanum Gothic'; font-size: 13px; font-style: normal; font-weight: 400; word-spacing: 0px; white-space: normal; border-collapse: collapse; table-layout: fixed; box-sizing: inherit; border-spacing: 0px; orphans: 2; widows: 2; background-color: rgb(255, 255, 255); text-decoration-color: initial; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-thickness: initial; text-decoration-style: initial; text-size-adjust: none;">
<tbody style="box-sizing: inherit; text-size-adjust: none;">
<tr style="box-sizing: inherit; text-size-adjust: none;">
<td valign="middle" style="background: rgb(242, 242, 242); margin: 0px; padding: 0px; border: 1px solid rgb(166, 166, 166); border-image: none; width: 100.02pt; height: 34.31pt; color: rgb(125, 125, 125); line-height: 1.6; font-family: 'Nanum Gothic'; font-size: 13px; box-sizing: inherit; text-size-adjust: none;">
의뢰자</td>
<td valign="middle" style="background: rgb(242, 242, 242); margin: 0px; padding: 0px; border: 1px solid rgb(166, 166, 166); border-image: none; width: 71.72pt; height: 34.31pt; color: rgb(125, 125, 125); line-height: 1.6; font-family: 'Nanum Gothic'; font-size: 13px; box-sizing: inherit; text-size-adjust: none;">
제품명</td>
<td valign="middle" style="background: rgb(242, 242, 242); margin: 0px; padding: 0px; border: 1px solid rgb(166, 166, 166); border-image: none; width: 255.02pt; height: 34.31pt; color: rgb(125, 125, 125); line-height: 1.6; font-family: 'Nanum Gothic'; font-size: 13px; box-sizing: inherit; text-size-adjust: none;">
임상시험제목</td>
<td valign="middle" style="background: rgb(242, 242, 242); margin: 0px; padding: 0px; border: 1px solid rgb(166, 166, 166); border-image: none; width: 68pt; height: 34.31pt; color: rgb(125, 125, 125); line-height: 1.6; font-family: 'Nanum Gothic'; font-size: 13px; box-sizing: inherit; text-size-adjust: none;">
임상시험 단계</td>
<td valign="middle" style="background: rgb(242, 242, 242); margin: 0px; padding: 0px; border: 1px solid rgb(166, 166, 166); border-image: none; width: 51.17pt; height: 34.31pt; color: rgb(125, 125, 125); line-height: 1.6; font-family: 'Nanum Gothic'; font-size: 13px; box-sizing: inherit; text-size-adjust: none;">
개발지역</td>
<td valign="middle" style="background: rgb(242, 242, 242); margin: 0px; padding: 0px; border: 1px solid rgb(166, 166, 166); border-image: none; width: 70.49pt; height: 34.31pt; color: rgb(125, 125, 125); line-height: 1.6; font-family: 'Nanum Gothic'; font-size: 13px; box-sizing: inherit; text-size-adjust: none;">
승인일</td>
</tr>
<tr style="box-sizing: inherit; text-size-adjust: none;">
<td valign="middle" style="margin: 0px; padding: 0px; border: 1px solid rgb(166, 166, 166); border-image: none; width: 100.02pt; height: 87.46pt; color: rgb(125, 125, 125); line-height: 1.6; font-family: 'Nanum Gothic'; font-size: 13px; box-sizing: inherit; text-size-adjust: none;">
한국아이큐비아(주)</td>
<td valign="middle" style="margin: 0px; padding: 0px; border: 1px solid rgb(166, 166, 166); border-image: none; width: 71.72pt; height: 87.46pt; color: rgb(125, 125, 125); line-height: 1.6; font-family: 'Nanum Gothic'; font-size: 13px; box-sizing: inherit; text-size-adjust: none;">
CAEL-101</td>
<td valign="middle" style="margin: 0px; padding: 0px; border: 1px solid rgb(166, 166, 166); border-image: none; width: 255.02pt; height: 87.46pt; color: rgb(125, 125, 125); line-height: 1.6; font-family: 'Nanum Gothic'; font-size: 13px; box-sizing: inherit; text-size-adjust: none;">
Mayo stage IIIb AL 아밀로이드증이 있으며 형질 세포 질환 치료 경험이 없는 시험대상자에서 CAEL-101 과 형질 세포 질환 치료 병용요법 대 위약과 형질 세포 질환 치료 병용요법의 유효성 및 안전성을 평가하는 제3상, 이중 눈가림, 다기관 시험</td>
<td valign="middle" style="margin: 0px; padding: 0px; border: 1px solid rgb(166, 166, 166); border-image: none; width: 68pt; height: 87.46pt; color: rgb(125, 125, 125); line-height: 1.6; font-family: 'Nanum Gothic'; font-size: 13px; box-sizing: inherit; text-size-adjust: none;">
3상</td>
<td valign="middle" style="margin: 0px; padding: 0px; border: 1px solid rgb(166, 166, 166); border-image: none; width: 51.17pt; height: 87.46pt; color: rgb(125, 125, 125); line-height: 1.6; font-family: 'Nanum Gothic'; font-size: 13px; box-sizing: inherit; text-size-adjust: none;">
국외개발</td>
<td valign="middle" style="margin: 0px; padding: 0px; border: 1px solid rgb(166, 166, 166); border-image: none; width: 70.49pt; height: 87.46pt; color: rgb(125, 125, 125); line-height: 1.6; font-family: 'Nanum Gothic'; font-size: 13px; box-sizing: inherit; text-size-adjust: none;">
2022-02-25</td>
</tr>
<tr style="box-sizing: inherit; text-size-adjust: none;">
<td valign="middle" style="margin: 0px; padding: 0px; border: 1px solid rgb(166, 166, 166); border-image: none; width: 100.02pt; height: 74.46pt; color: rgb(125, 125, 125); line-height: 1.6; font-family: 'Nanum Gothic'; font-size: 13px; box-sizing: inherit; text-size-adjust: none;">
한국파렉셀주식회사</td>
<td valign="middle" style="margin: 0px; padding: 0px; border: 1px solid rgb(166, 166, 166); border-image: none; width: 71.72pt; height: 74.46pt; color: rgb(125, 125, 125); line-height: 1.6; font-family: 'Nanum Gothic'; font-size: 13px; box-sizing: inherit; text-size-adjust: none;">
MEDI4736, MEDI9447, IPH2201</td>
<td valign="middle" style="margin: 0px; padding: 0px; border: 1px solid rgb(166, 166, 166); border-image: none; width: 255.02pt; height: 74.46pt; color: rgb(125, 125, 125); line-height: 1.6; font-family: 'Nanum Gothic'; font-size: 13px; box-sizing: inherit; text-size-adjust: none;">
절제 가능한 조기 병기 (II ~ IIIA) 비소세포 폐암 환자에 대한 수술 전 보조 및 수술 후 보조 치료의 제2상 라벨 공개, 다기관, 무작위 배정 임상시험 (NeoCOAST-2)</td>
<td valign="middle" style="margin: 0px; padding: 0px; border: 1px solid rgb(166, 166, 166); border-image: none; width: 68pt; height: 74.46pt; color: rgb(125, 125, 125); line-height: 1.6; font-family: 'Nanum Gothic'; font-size: 13px; box-sizing: inherit; text-size-adjust: none;">
2상</td>
<td valign="middle" style="margin: 0px; padding: 0px; border: 1px solid rgb(166, 166, 166); border-image: none; width: 51.17pt; height: 74.46pt; color: rgb(125, 125, 125); line-height: 1.6; font-family: 'Nanum Gothic'; font-size: 13px; box-sizing: inherit; text-size-adjust: none;">
국외개발</td>
<td valign="middle" style="margin: 0px; padding: 0px; border: 1px solid rgb(166, 166, 166); border-image: none; width: 70.49pt; height: 74.46pt; color: rgb(125, 125, 125); line-height: 1.6; font-family: 'Nanum Gothic'; font-size: 13px; box-sizing: inherit; text-size-adjust: none;">
2022-02-24</td>
</tr>
<tr style="box-sizing: inherit; text-size-adjust: none;">
<td valign="middle" style="margin: 0px; padding: 0px; border: 1px solid rgb(166, 166, 166); border-image: none; width: 100.02pt; height: 61.46pt; color: rgb(125, 125, 125); line-height: 1.6; font-family: 'Nanum Gothic'; font-size: 13px; box-sizing: inherit; text-size-adjust: none;">
코반스코리아서비스유한회사</td>
<td valign="middle" style="margin: 0px; padding: 0px; border: 1px solid rgb(166, 166, 166); border-image: none; width: 71.72pt; height: 61.46pt; color: rgb(125, 125, 125); line-height: 1.6; font-family: 'Nanum Gothic'; font-size: 13px; box-sizing: inherit; text-size-adjust: none;">
STRO-001</td>
<td valign="middle" style="margin: 0px; padding: 0px; border: 1px solid rgb(166, 166, 166); border-image: none; width: 255.02pt; height: 61.46pt; color: rgb(125, 125, 125); line-height: 1.6; font-family: 'Nanum Gothic'; font-size: 13px; box-sizing: inherit; text-size-adjust: none;">
진행성 B세포 악성종양 환자를 대상으로 한 항-CD74 항체 약물 접합체인 STRO-001의 제1상 공개, 안전성, 약동학 및 예비 유효성 시험</td>
<td valign="middle" style="margin: 0px; padding: 0px; border: 1px solid rgb(166, 166, 166); border-image: none; width: 68pt; height: 61.46pt; color: rgb(125, 125, 125); line-height: 1.6; font-family: 'Nanum Gothic'; font-size: 13px; box-sizing: inherit; text-size-adjust: none;">
1상</td>
<td valign="middle" style="margin: 0px; padding: 0px; border: 1px solid rgb(166, 166, 166); border-image: none; width: 51.17pt; height: 61.46pt; color: rgb(125, 125, 125); line-height: 1.6; font-family: 'Nanum Gothic'; font-size: 13px; box-sizing: inherit; text-size-adjust: none;">
국외개발</td>
<td valign="middle" style="margin: 0px; padding: 0px; border: 1px solid rgb(166, 166, 166); border-image: none; width: 70.49pt; height: 61.46pt; color: rgb(125, 125, 125); line-height: 1.6; font-family: 'Nanum Gothic'; font-size: 13px; box-sizing: inherit; text-size-adjust: none;">
2022-02-23</td>
</tr>
<tr style="box-sizing: inherit; text-size-adjust: none;">
<td valign="middle" style="margin: 0px; padding: 0px; border: 1px solid rgb(166, 166, 166); border-image: none; width: 100.02pt; height: 61.46pt; color: rgb(125, 125, 125); line-height: 1.6; font-family: 'Nanum Gothic'; font-size: 13px; box-sizing: inherit; text-size-adjust: none;">
피피디디벨럽먼트피티이엘티디</td>
<td valign="middle" style="margin: 0px; padding: 0px; border: 1px solid rgb(166, 166, 166); border-image: none; width: 71.72pt; height: 61.46pt; color: rgb(125, 125, 125); line-height: 1.6; font-family: 'Nanum Gothic'; font-size: 13px; box-sizing: inherit; text-size-adjust: none;">
NGM707</td>
<td valign="middle" style="margin: 0px; padding: 0px; border: 1px solid rgb(166, 166, 166); border-image: none; width: 255.02pt; height: 61.46pt; color: rgb(125, 125, 125); line-height: 1.6; font-family: 'Nanum Gothic'; font-size: 13px; box-sizing: inherit; text-size-adjust: none;">
진행성 또는 전이성 고형암에서 단독요법 및 펨브롤리주맙과 병용요법으로의 NGM707에 대한 제1/2상 용량 증가/확장 임상시험</td>
<td valign="middle" style="margin: 0px; padding: 0px; border: 1px solid rgb(166, 166, 166); border-image: none; width: 68pt; height: 61.46pt; color: rgb(125, 125, 125); line-height: 1.6; font-family: 'Nanum Gothic'; font-size: 13px; box-sizing: inherit; text-size-adjust: none;">
1/2상</td>
<td valign="middle" style="margin: 0px; padding: 0px; border: 1px solid rgb(166, 166, 166); border-image: none; width: 51.17pt; height: 61.46pt; color: rgb(125, 125, 125); line-height: 1.6; font-family: 'Nanum Gothic'; font-size: 13px; box-sizing: inherit; text-size-adjust: none;">
국외개발</td>
<td valign="middle" style="margin: 0px; padding: 0px; border: 1px solid rgb(166, 166, 166); border-image: none; width: 70.49pt; height: 61.46pt; color: rgb(125, 125, 125); line-height: 1.6; font-family: 'Nanum Gothic'; font-size: 13px; box-sizing: inherit; text-size-adjust: none;">
2022-02-21</td>
</tr>
</tbody>
</table>

<p align="left" style="margin: 0px; padding: 0px; color: rgb(125, 125, 125); text-transform: none; text-indent: 0px; letter-spacing: normal; font-family: 'Nanum Gothic'; font-size: 13px; font-style: normal; font-weight: 400; word-spacing: 0px; white-space: normal; box-sizing: inherit; orphans: 2; widows: 2; background-color: rgb(255, 255, 255); text-decoration-color: initial; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-thickness: initial; text-decoration-style: initial; text-size-adjust: none;" 255,="" rgb(255,="" 13px;="" nanum="">국내 바이오의약품 임상시험 현황입니다.<span style="color: rgb(125, 125, 125); text-transform: none; text-indent: 0px; letter-spacing: normal; font-family: 나눔고딕, NanumGothic, sans-serif; font-size: 10pt; font-style: normal; font-weight: 400; word-spacing: 0px; white-space: normal; box-sizing: inherit; orphans: 2; widows: 2; background-color: rgb(255, 255, 255); text-decoration-color: initial; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-thickness: initial; text-decoration-style: initial; text-size-adjust: none;"> <p style="margin: 0px; padding: 0px; color: rgb(125, 125, 125); text-transform: none; text-indent: 0px; letter-spacing: normal; font-family: 'Nanum Gothic'; font-size: 13px; font-style: normal; font-weight: 400; word-spacing: 0px; white-space: normal; box-sizing: inherit; orphans: 2; widows: 2; background-color: rgb(255, 255, 255); text-decoration-color: initial; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-thickness: initial; text-decoration-style: initial; text-size-adjust: none;" 255,="" rgb(255,="" 13px;="" nanum="">○기간: 2022.2.21. ~ 2022.2.25. <p style="margin: 0px; padding: 0px; color: rgb(125, 125, 125); text-transform: none; text-indent: 0px; letter-spacing: normal; font-family: 'Nanum Gothic'; font-size: 13px; font-style: normal; font-weight: 400; word-spacing: 0px; white-space: normal; box-sizing: inherit; orphans: 2; widows: 2; background-color: rgb(255, 255, 255); text-decoration-color: initial; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-thickness: initial; text-decoration-style: initial; text-size-adjust: none;" 255,="" rgb(255,="" 13px;="" nanum="">○출처: 의약품안전나라(의약품통합정보시스템) > 의약품등 정보 > 임상시험정보 > 임상시험정보공개 (<a style="border: 0px currentColor; border-image: none; color: rgb(125, 125, 125); text-decoration: none; box-sizing: inherit; text-size-adjust: none;" href="https://nedrug.mfds.go.kr/searchClinic" target="_self">링크 바로가기</a>) <p style="margin: 0px; padding: 0px; color: rgb(125, 125, 125); text-transform: none; text-indent: 0px; letter-spacing: normal; font-family: 'Nanum Gothic'; font-size: 13px; font-style: normal; font-weight: 400; word-spacing: 0px; white-space: normal; box-sizing: inherit; orphans: 2; widows: 2; background-color: rgb(255, 255, 255); text-decoration-color: initial; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-thickness: initial; text-decoration-style: initial; text-size-adjust: none;" 255,="" rgb(255,="" 13px;="" nanum=""> <table style="border: currentColor; border-image: none; color: rgb(125, 125, 125); text-transform: none; letter-spacing: normal; font-family: 'Nanum Gothic'; font-size: 13px; font-style: normal; font-weight: 400; word-spacing: 0px; white-space: normal; border-collapse: collapse; table-layout: fixed; box-sizing: inherit; border-spacing: 0px; orphans: 2; widows: 2; background-color: rgb(255, 255, 255); text-decoration-color: initial; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-thickness: initial; text-decoration-style: initial; text-size-adjust: none;"> <tbody style="box-sizing: inherit; text-size-adjust: none;"> <tr style="box-sizing: inherit; text-size-adjust: none;"> <td valign="middle" style="background: rgb(242, 242, 242); margin: 0px; padding: 0px; border: 1px solid rgb(166, 166, 166); border-image: none; width: 100.02pt; height: 34.31pt; color: rgb(125, 125, 125); line-height: 1.6; font-family: 'Nanum Gothic'; font-size: 13px; box-sizing: inherit; text-size-adjust: none;"> 의뢰자</td> <td valign="middle" style="background: rgb(242, 242, 242); margin: 0px; padding: 0px; border: 1px solid rgb(166, 166, 166); border-image: none; width: 71.72pt; height: 34.31pt; color: rgb(125, 125, 125); line-height: 1.6; font-family: 'Nanum Gothic'; font-size: 13px; box-sizing: inherit; text-size-adjust: none;"> 제품명</td> <td valign="middle" style="background: rgb(242, 242, 242); margin: 0px; padding: 0px; border: 1px solid rgb(166, 166, 166); border-image: none; width: 255.02pt; height: 34.31pt; color: rgb(125, 125, 125); line-height: 1.6; font-family: 'Nanum Gothic'; font-size: 13px; box-sizing: inherit; text-size-adjust: none;"> 임상시험제목</td> <td valign="middle" style="background: rgb(242, 242, 242); margin: 0px; padding: 0px; border: 1px solid rgb(166, 166, 166); border-image: none; width: 68pt; height: 34.31pt; color: rgb(125, 125, 125); line-height: 1.6; font-family: 'Nanum Gothic'; font-size: 13px; box-sizing: inherit; text-size-adjust: none;"> 임상시험 단계</td> <td valign="middle" style="background: rgb(242, 242, 242); margin: 0px; padding: 0px; border: 1px solid rgb(166, 166, 166); border-image: none; width: 51.17pt; height: 34.31pt; color: rgb(125, 125, 125); line-height: 1.6; font-family: 'Nanum Gothic'; font-size: 13px; box-sizing: inherit; text-size-adjust: none;"> 개발지역</td> <td valign="middle" style="background: rgb(242, 242, 242); margin: 0px; padding: 0px; border: 1px solid rgb(166, 166, 166); border-image: none; width: 70.49pt; height: 34.31pt; color: rgb(125, 125, 125); line-height: 1.6; font-family: 'Nanum Gothic'; font-size: 13px; box-sizing: inherit; text-size-adjust: none;"> 승인일</td> </tr> <tr style="box-sizing: inherit; text-size-adjust: none;"> <td valign="middle" style="margin: 0px; padding: 0px; border: 1px solid rgb(166, 166, 166); border-image: none; width: 100.02pt; height: 87.46pt; color: rgb(125, 125, 125); line-height: 1.6; font-family: 'Nanum Gothic'; font-size: 13px; box-sizing: inherit; text-size-adjust: none;"> 한국아이큐비아(주)</td> <td valign="middle" style="margin: 0px; padding: 0px; border: 1px solid rgb(166, 166, 166); border-image: none; width: 71.72pt; height: 87.46pt; color: rgb(125, 125, 125); line-height: 1.6; font-family: 'Nanum Gothic'; font-size: 13px; box-sizing: inherit; text-size-adjust: none;"> CAEL-101</td> <td valign="middle" style="margin: 0px; padding: 0px; border: 1px solid rgb(166, 166, 166); border-image: none; width: 255.02pt; height: 87.46pt; color: rgb(125, 125, 125); line-height: 1.6; font-family: 'Nanum Gothic'; font-size: 13px; box-sizing: inherit; text-size-adjust: none;"> Mayo stage IIIb AL 아밀로이드증이 있으며 형질 세포 질환 치료 경험이 없는 시험대상자에서 CAEL-101 과 형질 세포 질환 치료 병용요법 대 위약과 형질 세포 질환 치료 병용요법의 유효성 및 안전성을 평가하는 제3상, 이중 눈가림, 다기관 시험</td> <td valign="middle" style="margin: 0px; padding: 0px; border: 1px solid rgb(166, 166, 166); border-image: none; width: 68pt; height: 87.46pt; color: rgb(125, 125, 125); line-height: 1.6; font-family: 'Nanum Gothic'; font-size: 13px; box-sizing: inherit; text-size-adjust: none;"> 3상</td> <td valign="middle" style="margin: 0px; padding: 0px; border: 1px solid rgb(166, 166, 166); border-image: none; width: 51.17pt; height: 87.46pt; color: rgb(125, 125, 125); line-height: 1.6; font-family: 'Nanum Gothic'; font-size: 13px; box-sizing: inherit; text-size-adjust: none;"> 국외개발</td> <td valign="middle" style="margin: 0px; padding: 0px; border: 1px solid rgb(166, 166, 166); border-image: none; width: 70.49pt; height: 87.46pt; color: rgb(125, 125, 125); line-height: 1.6; font-family: 'Nanum Gothic'; font-size: 13px; box-sizing: inherit; text-size-adjust: none;"> 2022-02-25</td> </tr> <tr style="box-sizing: inherit; text-size-adjust: none;"> <td valign="middle" style="margin: 0px; padding: 0px; border: 1px solid rgb(166, 166, 166); border-image: none; width: 100.02pt; height: 74.46pt; color: rgb(125, 125, 125); line-height: 1.6; font-family: 'Nanum Gothic'; font-size: 13px; box-sizing: inherit; text-size-adjust: none;"> 한국파렉셀주식회사</td> <td valign="middle" style="margin: 0px; padding: 0px; border: 1px solid rgb(166, 166, 166); border-image: none; width: 71.72pt; height: 74.46pt; color: rgb(125, 125, 125); line-height: 1.6; font-family: 'Nanum Gothic'; font-size: 13px; box-sizing: inherit; text-size-adjust: none;"> MEDI4736, MEDI9447, IPH2201</td> <td valign="middle" style="margin: 0px; padding: 0px; border: 1px solid rgb(166, 166, 166); border-image: none; width: 255.02pt; height: 74.46pt; color: rgb(125, 125, 125); line-height: 1.6; font-family: 'Nanum Gothic'; font-size: 13px; box-sizing: inherit; text-size-adjust: none;"> 절제 가능한 조기 병기 (II ~ IIIA) 비소세포 폐암 환자에 대한 수술 전 보조 및 수술 후 보조 치료의 제2상 라벨 공개, 다기관, 무작위 배정 임상시험 (NeoCOAST-2)</td> <td valign="middle" style="margin: 0px; padding: 0px; border: 1px solid rgb(166, 166, 166); border-image: none; width: 68pt; height: 74.46pt; color: rgb(125, 125, 125); line-height: 1.6; font-family: 'Nanum Gothic'; font-size: 13px; box-sizing: inherit; text-size-adjust: none;"> 2상</td> <td valign="middle" style="margin: 0px; padding: 0px; border: 1px solid rgb(166, 166, 166); border-image: none; width: 51.17pt; height: 74.46pt; color: rgb(125, 125, 125); line-height: 1.6; font-family: 'Nanum Gothic'; font-size: 13px; box-sizing: inherit; text-size-adjust: none;"> 국외개발</td> <td valign="middle" style="margin: 0px; padding: 0px; border: 1px solid rgb(166, 166, 166); border-image: none; width: 70.49pt; height: 74.46pt; color: rgb(125, 125, 125); line-height: 1.6; font-family: 'Nanum Gothic'; font-size: 13px; box-sizing: inherit; text-size-adjust: none;"> 2022-02-24</td> </tr> <tr style="box-sizing: inherit; text-size-adjust: none;"> <td valign="middle" style="margin: 0px; padding: 0px; border: 1px solid rgb(166, 166, 166); border-image: none; width: 100.02pt; height: 61.46pt; color: rgb(125, 125, 125); line-height: 1.6; font-family: 'Nanum Gothic'; font-size: 13px; box-sizing: inherit; text-size-adjust: none;"> 코반스코리아서비스유한회사</td> <td valign="middle" style="margin: 0px; padding: 0px; border: 1px solid rgb(166, 166, 166); border-image: none; width: 71.72pt; height: 61.46pt; color: rgb(125, 125, 125); line-height: 1.6; font-family: 'Nanum Gothic'; font-size: 13px; box-sizing: inherit; text-size-adjust: none;"> STRO-001</td> <td valign="middle" style="margin: 0px; padding: 0px; border: 1px solid rgb(166, 166, 166); border-image: none; width: 255.02pt; height: 61.46pt; color: rgb(125, 125, 125); line-height: 1.6; font-family: 'Nanum Gothic'; font-size: 13px; box-sizing: inherit; text-size-adjust: none;"> 진행성 B세포 악성종양 환자를 대상으로 한 항-CD74 항체 약물 접합체인 STRO-001의 제1상 공개, 안전성, 약동학 및 예비 유효성 시험</td> <td valign="middle" style="margin: 0px; padding: 0px; border: 1px solid rgb(166, 166, 166); border-image: none; width: 68pt; height: 61.46pt; color: rgb(125, 125, 125); line-height: 1.6; font-family: 'Nanum Gothic'; font-size: 13px; box-sizing: inherit; text-size-adjust: none;"> 1상</td> <td valign="middle" style="margin: 0px; padding: 0px; border: 1px solid rgb(166, 166, 166); border-image: none; width: 51.17pt; height: 61.46pt; color: rgb(125, 125, 125); line-height: 1.6; font-family: 'Nanum Gothic'; font-size: 13px; box-sizing: inherit; text-size-adjust: none;"> 국외개발</td> <td valign="middle" style="margin: 0px; padding: 0px; border: 1px solid rgb(166, 166, 166); border-image: none; width: 70.49pt; height: 61.46pt; color: rgb(125, 125, 125); line-height: 1.6; font-family: 'Nanum Gothic'; font-size: 13px; box-sizing: inherit; text-size-adjust: none;"> 2022-02-23</td> </tr> <tr style="box-sizing: inherit; text-size-adjust: none;"> <td valign="middle" style="margin: 0px; padding: 0px; border: 1px solid rgb(166, 166, 166); border-image: none; width: 100.02pt; height: 61.46pt; color: rgb(125, 125, 125); line-height: 1.6; font-family: 'Nanum Gothic'; font-size: 13px; box-sizing: inherit; text-size-adjust: none;"> 피피디디벨럽먼트피티이엘티디</td> <td valign="middle" style="margin: 0px; padding: 0px; border: 1px solid rgb(166, 166, 166); border-image: none; width: 71.72pt; height: 61.46pt; color: rgb(125, 125, 125); line-height: 1.6; font-family: 'Nanum Gothic'; font-size: 13px; box-sizing: inherit; text-size-adjust: none;"> NGM707</td> <td valign="middle" style="margin: 0px; padding: 0px; border: 1px solid rgb(166, 166, 166); border-image: none; width: 255.02pt; height: 61.46pt; color: rgb(125, 125, 125); line-height: 1.6; font-family: 'Nanum Gothic'; font-size: 13px; box-sizing: inherit; text-size-adjust: none;"> 진행성 또는 전이성 고형암에서 단독요법 및 펨브롤리주맙과 병용요법으로의 NGM707에 대한 제1/2상 용량 증가/확장 임상시험</td> <td valign="middle" style="margin: 0px; padding: 0px; border: 1px solid rgb(166, 166, 166); border-image: none; width: 68pt; height: 61.46pt; color: rgb(125, 125, 125); line-height: 1.6; font-family: 'Nanum Gothic'; font-size: 13px; box-sizing: inherit; text-size-adjust: none;"> 1/2상</td> <td valign="middle" style="margin: 0px; padding: 0px; border: 1px solid rgb(166, 166, 166); border-image: none; width: 51.17pt; height: 61.46pt; color: rgb(125, 125, 125); line-height: 1.6; font-family: 'Nanum Gothic'; font-size: 13px; box-sizing: inherit; text-size-adjust: none;"> 국외개발</td> <td valign="middle" style="margin: 0px; padding: 0px; border: 1px solid rgb(166, 166, 166); border-image: none; width: 70.49pt; height: 61.46pt; color: rgb(125, 125, 125); line-height: 1.6; font-family: 'Nanum Gothic'; font-size: 13px; box-sizing: inherit; text-size-adjust: none;"> 2022-02-21</td> </tr> </tbody> </table> 
소스입니다. Ctrl+C를 눌러 클립보드로 복사하세요

제약산업정보포털

인기검색어 TOP 10

전체메뉴

글로벌제약산업정보

임상정보

국내 바이오의약품 임상 현황 (2022/2/21 ~ 2022/2/25)

관련기관 배너모음